30th July 2026
How AI Is Designing New Disease-Fighting Antibodies
Today’s scientific landscape highlights a revolution in how we manipulate the human immune system. Artificial intelligence is now actively designing optimized, disease-fighting antibodies and predicting complex immune structures . In cancer research, scientists are reprogramming immune cells to overcome exhaustion and fight solid tumors more effectively , , while uncovering how hidden lung cells actively resist these therapies . Beyond cancer, researchers are engineering specialized T cells to safely treat autoimmune diseases and using lab-grown human spleen models to test new vaccines . Finally, our overall health remains deeply tied to our biology, with studies revealing how aging weakens antibody quality and how specific gut bacteria directly influence the severity of multiple sclerosis .
Top 10 topics by publication and citation volume
T-cell and B-cell Immunology132
Single-cell and spatial transcriptomics82
CAR-T cell therapy research76
Cancer Immunotherapy and Biomarkers70
Immune cells in cancer56
vaccines and immunoinformatics approaches52
Immune Cell Function and Interaction48
interferon and immune responses45
Gut microbiota and health43
Immunotherapy and Immune Responses38
Extended Breakdown↓
The human immune system operates as a highly dynamic, decentralized network where cellular metabolism, epigenetic programming, and symbiotic microbial signals constantly negotiate the boundary between defense and self-destruction. In recent years, our understanding of this balance has shifted from broad cellular classifications to a highly resolved, molecular-level mapping of immune cell states. This transformation is reshaping how we approach chronic inflammation, aging, infectious diseases, and oncology, bridging the gap between basic immunobiology and clinical translation.
At the core of adaptive immunity, cellular metabolism and aging dictate the precision of our defenses. For instance, the signaling adaptor SLP-76 has been identified as a critical metabolic bridge, coupling T-cell receptor engagement to the glycolytic reprogramming required for CD8+ effector function and systemic immunometabolic homeostasis . When these metabolic and signaling pathways age, humoral immunity suffers. Research reveals that aging disrupts the affinity threshold required for naive B cells to participate in germinal centers, resulting in the selection of lower-affinity clones and the production of lower-quality antibodies . To combat such age-related and autoimmune dysregulation, therapeutic strategies are increasingly turning to allogeneic platforms. Among these, CD19-targeted engineered regulatory T cells (CAR19 EngTregs) show immense promise in treating B-cell-mediated autoimmune diseases by selectively depleting B cells and suppressing pathogenic inflammation without triggering severe cytokine release syndrome .
Unraveling these intricate, heterogeneous cellular networks requires cutting-edge analytical tools capable of capturing multiple layers of biological information simultaneously. The field of single-cell multiomics has taken a major leap forward with the development of the WTA NEXT workflow, which enables researchers to perform deep immune profiling across whole transcriptome mRNA, surface proteins, and VDJ immune receptor repertoires within a single, highly scalable assay . This level of granular resolution is vital for mapping the complex microenvironments of solid tumors and inflammatory tissues.
In oncology, understanding the cellular and molecular landscape of the tumor microenvironment is critical for overcoming therapeutic resistance. A primary obstacle in cellular immunotherapy is T-cell exhaustion. To address this, researchers have demonstrated that tuning the dosage of the transcription factor BACH2 establishes a favorable hierarchy of stem-like CAR-T cells, preventing terminal exhaustion and boosting efficacy against solid tumors . Furthermore, terminal exhaustion is driven by epigenetic scarring; specifically, a histone-DNA methylation circuit regulated by KDM5A/B and DNMT3A can be targeted to reverse exhaustion and restore effector function, sensitizing tumors to anti-PD-L1 therapies . Beyond T cells, other stromal and myeloid populations in the microenvironment actively suppress anti-tumor immunity. For example, a distinct cross-species population of lung-resident, nerve- and airway-associated interstitial macrophages (NAMs) has been shown to drive lung tumor progression and actively promote resistance to anti-PD-1 immunotherapies .
To accelerate the design of therapies targeting these complex pathways, computational biology and artificial intelligence are revolutionizing molecular engineering. Structural prediction engines like AlphaFold 3 are now being evaluated for their ability to model complex immune interactions, showing that high-confidence structural predictions correlate strongly with the binding affinity and breadth of broadly neutralizing influenza antibodies . Going a step further, generative large language models like "Ab-Affinity" are being paired with combinatorial algorithms to design optimized antibody variants with massive predicted affinity enhancements .
These computational designs must ultimately be validated in human-relevant systems before clinical entry. The development of human spleen organoids provides an innovative preclinical platform capable of modeling complex cellular diversity and humoral antibody responses to novel vaccines ex vivo . Within these vaccination contexts, researchers are also uncovering the precise cellular mechanisms of antigen cross-presentation, demonstrating that vaccine adjuvants induce inflammatory type 2 conventional dendritic cells that enhance CD8+ T-cell priming by inhibiting autophagy .
Finally, the delicate balance of host immunity is continuously shaped by innate signaling pathways and symbiotic relationships. In the realm of innate defense, the STING pathway represents a double-edged sword that must be carefully modulated. To harness this axis safely, lipid nanoparticle (LNP)-based delivery of mRNA encoding a universal STING mimic (uniSTING) has been designed to selectively trigger protective type I interferon responses while avoiding toxic pro-inflammatory NF-κB signaling, successfully breaking viral tolerance in chronic infection models . Simultaneously, the gut microbiome acts as a remote rheostat for systemic immunity. Species-level genetic variation within the gut symbiont Akkermansia muciniphila alters its production of vitamin K2, which has been identified as a key modulator of disease progression and severity in central nervous system autoimmunity like multiple sclerosis .
At the core of adaptive immunity, cellular metabolism and aging dictate the precision of our defenses. For instance, the signaling adaptor SLP-76 has been identified as a critical metabolic bridge, coupling T-cell receptor engagement to the glycolytic reprogramming required for CD8+ effector function and systemic immunometabolic homeostasis . When these metabolic and signaling pathways age, humoral immunity suffers. Research reveals that aging disrupts the affinity threshold required for naive B cells to participate in germinal centers, resulting in the selection of lower-affinity clones and the production of lower-quality antibodies . To combat such age-related and autoimmune dysregulation, therapeutic strategies are increasingly turning to allogeneic platforms. Among these, CD19-targeted engineered regulatory T cells (CAR19 EngTregs) show immense promise in treating B-cell-mediated autoimmune diseases by selectively depleting B cells and suppressing pathogenic inflammation without triggering severe cytokine release syndrome .
Unraveling these intricate, heterogeneous cellular networks requires cutting-edge analytical tools capable of capturing multiple layers of biological information simultaneously. The field of single-cell multiomics has taken a major leap forward with the development of the WTA NEXT workflow, which enables researchers to perform deep immune profiling across whole transcriptome mRNA, surface proteins, and VDJ immune receptor repertoires within a single, highly scalable assay . This level of granular resolution is vital for mapping the complex microenvironments of solid tumors and inflammatory tissues.
In oncology, understanding the cellular and molecular landscape of the tumor microenvironment is critical for overcoming therapeutic resistance. A primary obstacle in cellular immunotherapy is T-cell exhaustion. To address this, researchers have demonstrated that tuning the dosage of the transcription factor BACH2 establishes a favorable hierarchy of stem-like CAR-T cells, preventing terminal exhaustion and boosting efficacy against solid tumors . Furthermore, terminal exhaustion is driven by epigenetic scarring; specifically, a histone-DNA methylation circuit regulated by KDM5A/B and DNMT3A can be targeted to reverse exhaustion and restore effector function, sensitizing tumors to anti-PD-L1 therapies . Beyond T cells, other stromal and myeloid populations in the microenvironment actively suppress anti-tumor immunity. For example, a distinct cross-species population of lung-resident, nerve- and airway-associated interstitial macrophages (NAMs) has been shown to drive lung tumor progression and actively promote resistance to anti-PD-1 immunotherapies .
To accelerate the design of therapies targeting these complex pathways, computational biology and artificial intelligence are revolutionizing molecular engineering. Structural prediction engines like AlphaFold 3 are now being evaluated for their ability to model complex immune interactions, showing that high-confidence structural predictions correlate strongly with the binding affinity and breadth of broadly neutralizing influenza antibodies . Going a step further, generative large language models like "Ab-Affinity" are being paired with combinatorial algorithms to design optimized antibody variants with massive predicted affinity enhancements .
These computational designs must ultimately be validated in human-relevant systems before clinical entry. The development of human spleen organoids provides an innovative preclinical platform capable of modeling complex cellular diversity and humoral antibody responses to novel vaccines ex vivo . Within these vaccination contexts, researchers are also uncovering the precise cellular mechanisms of antigen cross-presentation, demonstrating that vaccine adjuvants induce inflammatory type 2 conventional dendritic cells that enhance CD8+ T-cell priming by inhibiting autophagy .
Finally, the delicate balance of host immunity is continuously shaped by innate signaling pathways and symbiotic relationships. In the realm of innate defense, the STING pathway represents a double-edged sword that must be carefully modulated. To harness this axis safely, lipid nanoparticle (LNP)-based delivery of mRNA encoding a universal STING mimic (uniSTING) has been designed to selectively trigger protective type I interferon responses while avoiding toxic pro-inflammatory NF-κB signaling, successfully breaking viral tolerance in chronic infection models . Simultaneously, the gut microbiome acts as a remote rheostat for systemic immunity. Species-level genetic variation within the gut symbiont Akkermansia muciniphila alters its production of vitamin K2, which has been identified as a key modulator of disease progression and severity in central nervous system autoimmunity like multiple sclerosis .
Latest Papers
[1]
Adaptor SLP-76 couples the TCR to glucose metabolism in T-cells with augmented obesity 2310033
T-cell and B-cell Immunology
[2]
Aging disrupts the affinity threshold for naïve B cell germinal center participation 2306948
T-cell and B-cell Immunology
[3]
A Complete Multiomic Solution: WTA NEXT Powers Deep Immune Profiling Across mRNA, Surface Proteins, and VDJ in One Assay 2259618
Single-cell and spatial transcriptomics
[4]
BACH2 dosage establishes the hierarchy of stemness and finetunes antitumor immunity in CAR T cells 2256626
CAR-T cell therapy research
[5]
Decoding Histone-DNA Methylation Crosstalk in Exhausted T Cells to Enhance Immunotherapy 2253691
Cancer Immunotherapy and Biomarkers
[6]
[7]
Evaluating AlphaFold 3 immune complex structure prediction and cryo-EM analysis of broadly neutralizing antibodies towards influenza hemagglutinin 2309571
vaccines and immunoinformatics approaches
[8]
Experimental Validation of Variant Antibodies Guided by a Large Language Model and Optimized through Combinatorial Algorithms 2307181
vaccines and immunoinformatics approaches
[9]
A novel LNP/mRNA-based STING immunotherapy approach for chronic HBV infection 2334947
interferon and immune responses
[10]
[11]
Human Spleen Organoids as a Preclinical Platform for Evaluating Vaccine-Induced Antibody Responses 2261165
Immunotherapy and Immune Responses
[12]
[13]